Humana (HUM) FY2013 results: revenue $41.3 billion, up 5.6% on the year
Humana Inc. (HUM) reported revenue of $41.3 billion for fiscal 2013, the year ended 31 December 2013, up 5.6% on the year before. Net income was $1.2 billion, up 0.7%, and diluted earnings per share $7.73. The figures are the company's own, from the 10-K it filed with the SEC on 19 February 2014.
Revenue
$41.3 billion
+5.6% on the year
FY2007FY2013
Operating margin
5.0%
5.2% a year earlier
FY2007FY2013
Net income
$1.2 billion
+0.7% on the year
FY2007FY2013
Diluted EPS
$7.73
+3.5% on the year
FY2007FY2013
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Revenue
41,313
39,126
36,832
+5.6%
Selling, general and administrative
6,355
5,830
5,395
+9.0%
Operating income
2,061
2,016
2,344
+2.2%
Operating margin
5.0%
5.2%
6.4%
Interest expense
140
105
109
+33.3%
Pre-tax income
1,921
1,911
2,235
+0.5%
Income tax
690
689
816
+0.1%
Effective tax rate
35.9%
36.1%
36.5%
Net income
1,231
1,222
1,419
+0.7%
Net margin
3.0%
3.1%
3.9%
Diluted EPS
$7.73
$7.47
$8.46
+3.5%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Operating cash flow
1,716
1,923
2,079
-10.8%
Capital expenditure
441
410
346
+7.6%
Free cash flow
1,275
1,513
1,733
-15.7%
Free cash flow margin
3.1%
3.9%
4.7%
Cash from investing
-1,182
-1,965
-1,358
Cash from financing
-702
-29.0
-1,017
Depreciation and amortisation
309
338
303
-8.6%
Share-based compensation
92.0
82.0
67.0
+12.2%
Buybacks
531
518
541
+2.5%
Dividends paid
168
165
82.0
+1.8%
Dividend per share
$1.07
$1.03
$0.75
+3.9%
Diluted shares, weighted
159m
163m
168m
-2.6%
Balance sheet
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Shareholders' equity
9,316
8,847
8,063
+5.3%
Debt
3,003
2,935
1,965
+2.3%
Other liabilities
8,416
8,197
7,680
+2.7%
Total liabilities and equity
20,735
19,979
17,708
+3.8%
Fixed assets
1,218
1,098
912
+10.9%
Goodwill
3,253
3,640
2,740
-10.6%
Intangible assets
693
731
435
-5.2%
Investments
9,800
9,847
9,453
-0.5%
Cash and equivalents
1,138
1,306
1,377
-12.9%
Receivables
950
733
1,034
+29.6%
Other assets
3,683
2,624
1,757
+40.4%
Total assets
20,735
19,979
17,708
+3.8%
10-K for the year ended 31 December 2013, filed 19 February 2014: the filing.